期刊
INDIAN JOURNAL OF ANAESTHESIA
卷 61, 期 10, 页码 798-802出版社
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/ija.IJA_210_17
关键词
Pulmonary artery pressure; sildenafil; ventricular septal defect
Background and Aims: Sildenafil is known to reduce pulmonary artery pressure but its role in the perioperative period has not been well studied. We aimed to evaluate the efficacy of sildenafil in controlling post-operative pulmonary hypertension in children with pulmonary hypertension undergoing surgeries for correction of ventricular septal defect. Methods: The patients were divided randomly into two groups of thirty each. Group 1 (placebo) received pre-operative placebo and post-operative sildenafil (0.5mg/kg every 6 hrs) while Group 2 (sildenafil) received pre-and post-operative sildenafil (0.5mg/kg every 6 hrs) Results: In the Group 1, systolic pulmonary artery pressure reduced from 81.63 (+/-12.1) mmHg preoperatively to 79.26 (+/- 11.29) mmHg pre-cardiopulmonary bypass (CPB) and 56.76 (+/- 11) mmHg (with 10 minutes post-CPB), whereas in Group 2, it reduced from 83.3 (+/- 12.1) before surgery to 68.9 (+/- 11.3) mmHg pre-CPB and after CPB, to 42.2 (+/- 7.6) mmHg (P = 0.001). The mean pulmonary artery pressure decreased from 60.63 (+/- 10.5) mmHg to 42.13 (+/- 8.3) mmHg in the Group 1 whereas it reduced from 54.36 (+/- 10) mmHg to 31.36 (+/- 6.5) mmHg in Group 2 (P = 0.001). The reductions in pulmonary artery/aortic ratio and Intensive Care Unit stay were statistically significant No adverse effects were recorded. Conclusion: The use of perioperative sildenafil has a statistically significant reduction in the mean pulmonary artery pressure without any adverse effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据